MedElevator
Войти в исследования Pediatric endocrinology, diabetes, and metabolism · 2026
Examination of factors affecting adropin levels in healthy and obese children.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dişçi Esra, Kaya Serap Kılıç, Dönmez Ayşe Sena, Cayir Atilla, Laloğlu Esra, Kaşali Kamber, Akgül Büşra Nur
Аннотация
INTRODUCTION: There are very different reports regarding whether adropin levels are low, moderate, or high in childhood obesity and obesity-related comorbidities. However, data on the effects of age, sex, and puberty are insufficient.
MATERIAL AND METHODS: We planned a case-control study consisting of 59 obese patients (female [F] = 35/male [M] = 24) and 40 healthy controls (F = 21/M = 19). Additionally, obese children were re-evaluated following a 12-week diet intervention. Serum glucose, insulin, lipid profiles, liver function tests, and adropin levels were examined.
RESULTS: While age (12.5 ±4.1 years vs. 9.9 ±4.7 years, p = 0.006), body mass index (BMI) standard deviation score (SDS) (3.1 ±0.7 standard deviation [SD] vs. -0.3 ±0.8 SD, p < 0.001), and alanine aminotransferase (ALT) (30 ±16.9 U/l vs. 17.7 ±7.1 U/l, p < 0.001) were higher in obese children, adropin (212.2 ±67.7 ng/l vs. 369.2 ±64.6 ng/l, p < 0.001) was lower than healthy controls. When age, sex, BMI SDS, and ALT were evaluated together in multivariate regression analysis (all patients), BMI SDS was found to be the only independent factor effecting adropin level ( = -0.6, p < 0.001). We observed an increase in adropin levels compared to baseline following 12-week diet intervention, in obese children (212.2 ±67.7 ng/l vs. 237.4 ±87.3 ng/l, p = 0.03).
CONCLUSIONS: The effect of parameters such as age, sex, and BMI SDS on adropin shows that the only independent factor effecting the alteration of adropin level is BMI SDS.
MATERIAL AND METHODS: We planned a case-control study consisting of 59 obese patients (female [F] = 35/male [M] = 24) and 40 healthy controls (F = 21/M = 19). Additionally, obese children were re-evaluated following a 12-week diet intervention. Serum glucose, insulin, lipid profiles, liver function tests, and adropin levels were examined.
RESULTS: While age (12.5 ±4.1 years vs. 9.9 ±4.7 years, p = 0.006), body mass index (BMI) standard deviation score (SDS) (3.1 ±0.7 standard deviation [SD] vs. -0.3 ±0.8 SD, p < 0.001), and alanine aminotransferase (ALT) (30 ±16.9 U/l vs. 17.7 ±7.1 U/l, p < 0.001) were higher in obese children, adropin (212.2 ±67.7 ng/l vs. 369.2 ±64.6 ng/l, p < 0.001) was lower than healthy controls. When age, sex, BMI SDS, and ALT were evaluated together in multivariate regression analysis (all patients), BMI SDS was found to be the only independent factor effecting adropin level ( = -0.6, p < 0.001). We observed an increase in adropin levels compared to baseline following 12-week diet intervention, in obese children (212.2 ±67.7 ng/l vs. 237.4 ±87.3 ng/l, p = 0.03).
CONCLUSIONS: The effect of parameters such as age, sex, and BMI SDS on adropin shows that the only independent factor effecting the alteration of adropin level is BMI SDS.